道琼斯指数
52,378.4
涨跌
+16.82+0.03%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场整体上涨,道琼斯指数上涨 0.03%,标普 500 指数上涨 0.60%,纳斯达克综合指数上涨 1.18%。市场广度同样偏强,2,687 只股票上涨、2,431 只下跌,整体呈现偏多格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | Solid Biosciences Inc.SLDB | $6.18 | +6.37% | 1.34M | $662.97M | $3.79 - $11.45 | 0.00% |
| 52 | 4D Molecular Therapeutics, Inc.FDMT | $11.96 | +8.61% | 891.44K | $661.00M | $6.96 - $16.93 | 0.00% |
| 53 | Aura Biosciences, Inc.AURA | $6.29 | +1.78% | 498.77K | $652.51M | $4.73 - $9.54 | 0.00% |
| 54 | DBV Technologies S.A.DBVT | $10.12 | +1.45% | 610.47K | $636.20M | $8.63 - $26.18 | 0.00% |
| 55 | Candel Therapeutics, Inc.CADL | $8.26 | +6.10% | 759.18K | $631.66M | $4.35 - $14.00 | 0.00% |
| 56 | Attovia Therapeutics, Inc.ATTO | $15.01 | +8.14% | 428.12K | $631.36M | $12.94 - $28.00 | 0.00% |
| 57 | Ginkgo Bioworks Holdings, Inc.DNA | $11.26 | +12.48% | 2.56M | $623.62M | $5.37 - $18.22 | 0.00% |
| 58 | Entera Bio Ltd.ENTX | $3.06 | +7.69% | 198.59K | $532.38M | $0.91 - $4.20 | 0.00% |
| 59 | NRC HealthNRC | $21.55 | -3.74% | 72.13K | $485.73M | $11.32 - $23.68 | 0.03% |
| 60 | REGENXBIO Inc.RGNX | $6.60 | +0.15% | 975.96K | $435.62M | $5.46 - $16.19 | 0.00% |
| 61 | Allogene Therapeutics, Inc.ALLO | $1.23 | +1.65% | 15.35M | $423.23M | $1.04 - $4.46 | 0.00% |
| 62 | Zura Bio LimitedZURA | $4.29 | +20.22% | 4.65M | $410.63M | $3.25 - $7.44 | 0.00% |
| 63 | Editas Medicine, Inc.EDIT | $2.60 | +8.75% | 2.67M | $400.08M | $1.66 - $3.94 | 0.00% |
| 64 | Tectonic Therapeutic, Inc.TECX | $20.33 | +1.93% | 177.66K | $397.40M | $15.52 - $39.53 | 0.00% |
| 65 | C4 Therapeutics, Inc.CCCC | $3.22 | +8.05% | 3.79M | $396.63M | $1.69 - $5.17 | 0.00% |
| 66 | Eikon Therapeutics, Inc.EIKN | $5.55 | -0.18% | 615.80K | $393.24M | $5.44 - $17.40 | 0.00% |
| 67 | Fennec Pharmaceuticals Inc.FENC | $10.61 | +4.73% | 62.33K | $372.89M | $5.65 - $13.25 | 0.00% |
| 68 | Kyverna Therapeutics, Inc.KYTX | $5.64 | +7.12% | 752.62K | $349.11M | $5.15 - $13.67 | 0.00% |
| 69 | IRulya Therapeutics Inc.IRLA | $32.13 | +5.31% | 126.99K | $348.31M | $25.13 - $41.00 | 0.00% |
| 70 | Surrozen, Inc.SRZN | $29.50 | +8.03% | 403.29K | $342.55M | $11.39 - $37.83 | 0.00% |
| 71 | X4 Pharmaceuticals, Inc.XFOR | $3.27 | +0.46% | 1.44M | $323.71M | $2.43 - $4.83 | 0.00% |
| 72 | ProKidney Corp.PROK | $1.52 | +11.76% | 1.19M | $318.61M | $1.30 - $3.48 | 0.00% |
| 73 | Agenus Inc.AGEN | $6.66 | +8.12% | 719.49K | $300.55M | $2.71 - $10.31 | 0.00% |
| 74 | Scribe Therapeutics Inc.SCTX | $15.97 | +2.60% | 534.44K | $291.64M | $13.50 - $39.60 | 0.00% |
| 75 | SAB Biotherapeutics, Inc.SABS | $3.08 | +10.39% | 557.18K | $279.78M | $2.44 - $5.15 | 0.00% |
| 76 | Century Therapeutics, Inc.IPSC | $1.45 | +1.41% | 582.86K | $261.65M | $0.43 - $3.04 | 0.00% |
| 77 | Ocugen, Inc.OCGN | $0.77 | +8.12% | 7.69M | $259.76M | $0.70 - $2.73 | 0.00% |
| 78 | Fate Therapeutics, Inc.FATE | $2.07 | +0.49% | 880.41K | $248.03M | $0.95 - $3.23 | 0.00% |
| 79 | Cabaletta Bio, Inc.CABA | $1.45 | +7.41% | 6.00M | $244.99M | $1.32 - $4.23 | 0.00% |
| 80 | Alector, Inc.ALEC | $2.11 | +14.75% | 4.27M | $235.60M | $1.09 - $2.76 | 0.00% |
| 81 | Lexeo Therapeutics, Inc.LXEO | $2.87 | +5.93% | 2.24M | $235.06M | $2.55 - $10.99 | 0.00% |
| 82 | Inhibikase Therapeutics, Inc.IKT | $1.56 | +2.96% | 1.05M | $218.37M | $1.33 - $2.61 | 0.00% |
| 83 | Palisade Bio, Inc.PALI | $1.20 | -3.25% | 5.73M | $208.25M | $1.18 - $2.85 | 0.00% |
| 84 | Artiva Biotherapeutics, Inc.ARTV | $4.25 | -30.84% | 8.25M | $207.93M | $2.96 - $14.53 | 0.00% |
| 85 | Alpha Cognition Inc.ACOG | $8.96 | +6.99% | 150.43K | $195.20M | $4.50 - $10.14 | 0.00% |
| 86 | Precision BioSciences, Inc.DTIL | $6.79 | +6.24% | 136.98K | $187.47M | $3.53 - $9.62 | 0.00% |
| 87 | Invivyd, Inc.IVVD | $0.60 | +1.75% | 3.90M | $176.56M | $0.53 - $3.07 | 0.00% |
| 88 | Coherus Oncology, Inc.CHRS | $1.06 | +5.94% | 545.46K | $164.54M | $0.94 - $2.62 | 0.00% |
| 89 | Acumen Pharmaceuticals, Inc.ABOS | $2.27 | +0.44% | 1.68M | $164.45M | $1.50 - $3.60 | 0.00% |
| 90 | MaxCyte, Inc.MXCT | $1.53 | +1.99% | 1.50M | $158.42M | $0.64 - $1.80 | 0.00% |
| 91 | Sutro Biopharma, Inc.STRO | $8.87 | -0.45% | 395.95K | $147.07M | $7.15 - $43.85 | 0.00% |
| 92 | Protara Therapeutics, Inc.TARA | $2.46 | +4.89% | 1.69M | $145.67M | $2.27 - $7.82 | 0.00% |
| 93 | Compass Therapeutics, Inc.CMPX | $0.75 | +0.62% | 1.66M | $134.53M | $0.73 - $6.88 | 0.00% |
| 94 | Outlook Therapeutics, Inc.OTLK | $0.53 | +3.95% | 3.20M | $129.27M | $0.16 - $2.54 | 0.00% |
| 95 | Humacyte, Inc.HUMA | $0.45 | +11.61% | 3.68M | $124.18M | $0.34 - $1.78 | 0.00% |
| 96 | Anavex Life SciencesAVXL | $1.30 | +1.56% | 1.11M | $120.97M | $1.14 - $8.79 | 0.00% |
| 97 | Voyager Therapeutics, Inc.VYGR | $1.75 | -0.29% | 1.09M | $107.52M | $1.71 - $5.48 | 0.00% |
| 98 | enGene Therapeutics Inc.ENGN | $1.55 | -1.90% | 338.36K | $104.21M | $1.40 - $12.25 | 0.00% |
| 99 | Tevogen Inc.TVGN | $6.38 | +1.34% | 5.13K | $100.32M | $3.64 - $32.90 | 0.00% |
| 100 | Black Diamond Therapeutics, Inc.BDTX | $1.75 | +3.25% | 1.00M | $100.26M | $1.60 - $4.94 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。